REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 48 filers reported holding REGULUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $18,000 | – | 22,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,401,491 | $968,000 | 0.58% |
| Endurant Capital Management LP | 3,547,208 | $2,450,000 | 0.56% |
| Sarissa Capital Management LP | 1,851,851 | $1,279,000 | 0.10% |
| Ikarian Capital, LLC | 1,228,416 | $849,000 | 0.06% |
| NEA Management Company, LLC | 6,451,056 | $4,455,000 | 0.05% |
| GYL FINANCIAL SYNERGIES, LLC | 41,000 | $28,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 64,708 | $45,000 | 0.01% |
| All Terrain Financial Advisors, LLC | 15,000 | $10,000 | 0.00% |
| WealthTrust Axiom LLC | 13,000 | $8,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 2,227,212 | $1,538,000 | 0.00% |